The physiological relevance of a preference for the inactivated state of NaV1.7 in other pathological pain conditions remains to be established, although such a mechanism might imply lack of efficacy in paroxysmal extreme pain disorder, where NaV1.7 channels are relatively resistant to fast inactivation. This evidence concerns the gene SCN9A and paroxysmal extreme pain disorder.